netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 2: Cardiovascular system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
02.01 Positive inotropic drugs (0,0)
02.01.01 Cardiac glycosides (2,0)
spacespace Digoxin-specific antibody (1,2)
02.01.02 Phosphodiesterase type-3 inhibitors (2,0)
02.02 Diuretics (0,0)
02.02.01 Thiazides and related diuretics (3,5)
02.02.02 Loop diuretics (3,1)
02.02.03 Potassium-sparing diuretics and aldosterone antagonists (1,1)
spacespace Aldosterone antagonists (2,0)
02.02.04 Potassium-sparing diuretics with other diuretics (2,8)
02.02.05 Osmotic diuretics (1,0)
02.02.06 Mercurial diuretics (0,0)
02.02.07 Carbonic anhydrase inhibitors (0,0)
02.02.08 Diuretics with potassium (0,5)
02.03 Anti-arrhythmic drugs (0,0)
02.03.01 Management of arrhythmias (0,0)
02.03.02 Drugs for arrhythmias (0,1)
spacespace Supraventricular arrhythmias (3,0)
spacespace Supraventricular and ventricular arrhythmias (7,2)
spacespace Ventricular arrhythmias (1,0)
02.04 Beta-adrenoceptor blocking drugs (10,24)
02.05 Drugs affecting the renin-angiotensin system and some other antihypertensive drugs (0,0)
02.05.01 Vasodilator antihypertensive drugs (5,14)
02.05.02 Centrally acting antihypertensive drugs (2,1)
02.05.03 Adrenergic neurone blocking drugs (0,1)
02.05.04 Alpha-adrenoceptor blocking drugs (1,6)
spacespace Phaeochromocytoma (2,0)
02.05.05 Drugs affecting the renin-angiotensin system (0,1)
02.05.05.01 Angiotensin-converting enzyme inhibitors (ACE inhibitors) (3,15)
02.05.05.02 Angiotensin-II receptor antagonists (3,7)
02.05.05.03 Renin inhibitors (0,2)
02.06 Nitrates, calcium-channel blockers, and potassium-channel activators (0,0)
02.06.01 Nitrates (5,0)
02.06.02 Calcium-channel blockers (8,20)
02.06.03 Other anitanginal drugs (4,0)
02.06.04 Peripheral vasodilators and related drugs (1,4)
02.07 Sympathomimetics (0,0)
02.07.01 Inotropic sympathomimetics (4,2)
02.07.02 Vasoconstrictor sympathomimetics (5,0)
02.07.03 Cardiopulmonary resuscitation (1,0)
02.08 Anticoagulants (0,0)
02.08.01 Parenteral anticoagulants (1,0)
spacespace Heparin (1,0)
spacespace Low molecular weight heparins (1,3)
spacespace Heparinoids (1,0)
spacespace Hirudins (1,1)
spacespace Heparin flushes (2,2)
spacespace Epoprostenol (1,0)
spacespace Fondaparinux (1,0)
02.08.02 Oral anticoagulants (6,1)
spacespace VTE treatment (0,0)
spacespace VTE prophylaxis in hip/knee surgery (0,0)
spacespace Antidotes (0,0)
02.08.03 Protamine sulphate (3,0)
02.09 Antiplatelet drugs (7,6)
02.10 Stable angina, acute coronary syndromes, and fibrinolysis (0,0)
02.10.01 Management of stable angina and acute coronary syndromes (0,0)
02.10.02 Fibrinolytic drugs (5,1)
02.11 Antifibrinolytic drugs and haemostatics (3,7)
spacespace Blood-related products (1,10)
02.12 Lipid-regulating drugs (2,3)
spacespace Bile acid sequestrants (1,2)
spacespace Ezetimibe (1,0)
spacespace Fibrates (2,3)
spacespace Statins (4,3)
02.13 Local sclerosants (1,1)
netFormulary